captopril has been researched along with Stroke in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 17 (68.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Negandhi, A; Smeda, JS; Stuckless, J; Watson, D | 1 |
| Deng, YT; Li, CG; Li, HM; Li, MC; Liu, SQ; Su, YY; Wei, JP; Xie, HF; Yan, ZX; Zheng, WX | 1 |
| Chen, PC; Hsu, CY; Huang, LY; Lee, JD; Lee, M; Ovbiagele, B; Saver, JL; Wu, YL | 1 |
| Califf, RM; Kober, L; Lewis, EF; Li, Y; Pfeffer, MA; Reed, SD; Rouleau, JL; Schulman, KA; Solomon, SD; Velazquez, EJ; Weinfurt, KP; White, HD | 1 |
| Kato, H; Murakami, M; Murakami, T; Ninomiya, T; Osajima, K; Otani, L | 1 |
| Davis, LA; Smeda, JS | 1 |
| Daneshtalab, N; Smeda, JS | 1 |
| Dorrance, AM; Lewis, RW; Mills, TM | 1 |
| Danchin, N | 1 |
| Bacellar, A; Oliveira-Filho, J; Pedreira, BB; Silva, SC; Sousa, EU; Trabuco, CC | 1 |
| Aronow, WS; Frishman, WH | 1 |
| Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ | 1 |
| Dickstein, K; Lehto, M; Nieminen, MS; Snapinn, S; Swedberg, K | 1 |
| Blume, A; Culman, J; Gohlke, P; Kreutz, R; Rösch, N; Scholz, A; Unger, T; Xu, J | 1 |
| Califf, R; Howlett, J; Køber, L; Maggioni, A; McMurray, J; Pfeffer, M; Pieper, K; Reed, S; Rouleau, J; Solomon, S; Swedberg, K; Van de Werf, F; Velazquez, E; White, H | 1 |
| McGuire, JJ; Smeda, JS | 1 |
| Califf, RM; Howlett, J; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Signorovitch, J; Solomon, SD; Thune, JJ; Velazquez, EJ; Zelenkofske, S | 1 |
| King, SR; Smeda, J; Vasdev, S | 1 |
| Achard, JM; Esper, NE; Fournier, A; Makdassi, R; Mazouz, H; Oprisiu, R; Pruna, A; Westeel, PF | 1 |
| Luft, FC | 1 |
| Hata, A; Ikeda, Y; Kimura, H; Mochizuki, S; Nakamura, T; Obata, JE; Shido, K; Takano, H; Takeda, S; Yoshida, Y | 1 |
| Bertrand, M; Boccara, G; Godet, G; Koskas, F; Van de Steen, E | 1 |
| Francis, GS; Gassler, JP | 1 |
| Hansson, L; Hedner, T; Lanke, J; Niklason, A; Niskanen, L | 1 |
3 review(s) available for captopril and Stroke
| Article | Year |
|---|---|
Treatment of hypertension and prevention of ischemic stroke.
Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke | 2004 |
Captopril prevention project--what shall we do about captopril and the risk of stroke?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain Ischemia; Captopril; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke | 2000 |
STOPPING at the CAPPP of good HOPE.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Ischemia; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2000 |
6 trial(s) available for captopril and Stroke
| Article | Year |
|---|---|
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Myocardial Infarction; Quality of Life; Recurrence; Stroke; Survivors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset.
Topics: Acute Disease; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Female; Humans; Hypertension; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Treatment Outcome | 2003 |
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Captopril; Epidemiologic Methods; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke; Ventricular Dysfunction, Left | 2005 |
Captopril prevention project--what shall we do about captopril and the risk of stroke?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain Ischemia; Captopril; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke | 2000 |
Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Meta-Analysis as Topic; Myocardial Infarction; Prospective Studies; Stroke; Survival Rate; Treatment Outcome | 1999 |
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Captopril; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Complications; Diabetic Angiopathies; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Morbidity; Myocardial Infarction; Prospective Studies; Risk; Stroke | 2001 |
17 other study(ies) available for captopril and Stroke
| Article | Year |
|---|---|
Post-stroke losartan and captopril treatments arrest hemorrhagic expansion in SHRsp without lowering blood pressure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Edema; Captopril; Cerebral Hemorrhage; Cerebrum; Disease Models, Animal; Disease Progression; Losartan; Male; Rats, Inbred WKY; Renin-Angiotensin System; Serum Albumin; Stroke; Time Factors | 2018 |
Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Cell Cycle Proteins; Cold Temperature; Humans; Kidney; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Renin-Angiotensin System; Stroke; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2019 |
Oral short-acting antihypertensive medications and the occurrence of stroke: a nationwide case-crossover study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Captopril; Cerebral Hemorrhage; Female; Humans; Labetalol; Male; Middle Aged; Nifedipine; Retrospective Studies; Stroke | 2019 |
Sardine peptide with angiotensin I-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Fishes; Hyperglycemia; Hypertension; Kidney Diseases; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Stroke | 2009 |
Captopril treatment temporarily restores cerebral blood flow autoregulation in spontaneously hypertensive rats after hemorrhagic stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebral Hemorrhage; Cerebrovascular Circulation; Homeostasis; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Survival Rate | 2010 |
The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood-Brain Barrier; Brain; Captopril; Cerebral Hemorrhage; Cerebrovascular Circulation; Diet; Homeostasis; Losartan; Middle Cerebral Artery; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Stroke; Vasoconstriction | 2011 |
Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Erectile Dysfunction; Genetic Predisposition to Disease; Hypertension; Male; Penile Erection; Rats; Rats, Inbred SHR; Stroke | 2002 |
[Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Female; Humans; Length of Stay; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension; Lithium; Lithium Chloride; Male; Potassium; Rats; Rats, Inbred SHR; Renin; Sodium; Sodium, Dietary; Stroke | 2005 |
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angina Pectoris; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cardiovascular Diseases; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Valine; Valsartan | 2006 |
Effects of poststroke losartan versus captopril treatment on myogenic and endothelial function in the cerebrovasculature of SHRsp.
Topics: Animals; Antihypertensive Agents; Captopril; Cerebrovascular Circulation; Endothelium, Vascular; Losartan; Male; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Stroke; Vascular Diseases; Vasodilation | 2007 |
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Effect of poststroke captopril treatment on mortality associated with hemorrhagic stroke in stroke-prone rats.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Captopril; Cerebral Hemorrhage; Dexamethasone; Drug Interactions; Hydralazine; Hypertension; Male; Rats; Rats, Inbred SHR; Spironolactone; Stroke; Survival Rate; Time Factors | 1999 |
Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Captopril; Collagen; Fibrosis; Heart; Heart Ventricles; Hemodynamics; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Myosin Heavy Chains; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tetrazoles | 2000 |
[Thrombopenia increased by heparin and danaparoid].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Captopril; Carotid Stenosis; Chondroitin Sulfates; Dermatan Sulfate; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Hypertension; Stroke; Thrombocytopenia | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |